登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《European Heart J，3月18日，Coronaviruses and the cardiovascular system: acute and long-term implications》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-19

  • Coronaviruses and the cardiovascular system: acute and long-term implications

    Tian-Yuan Xiong, Simon Redwood, Bernard Prendergast, Mao Chen

    European Heart Journal, ehaa231, https://doi.org/10.1093/eurheartj/ehaa231

    Published: 18 March 2020

    The recent outbreak of coronavirus disease 2019 (COVID-19) provides a further challenge in the battle against outbreaks of novel virus infections and has been declared a public health emergency of international concern. Much has been learnt in the course of preceding epidemics, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and H1N1 influenza, and it is now recognized that their overall health burden may be under-estimated since extra-pulmonary manifestations are frequent.1 Acute and chronic cardiovascular complications of pneumonia are common and result from various mechanisms, including relative ischaemia, systemic inflammation, and pathogen-mediated damage.

  • 原文来源：https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa231/5809453?searchresult=1
62浏览量
原文链接
相关报告

  • 《European Heart J，3月20日，SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-23
    • SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Gabriela M Kuster, Otmar Pfister, Thilo Burkard, Qian Zhou, Raphael Twerenbold, Philip Haaf, Andreas F Widmer, Stefan Osswald European Heart Journal, ehaa235, https://doi.org/10.1093/eurheartj/ehaa235 Published: 20 March 2020 In a rapid response published online by the British Medical Journal, Sommerstein and Gräni1 pushed forward the hypothesis that angiotensin-converting enzyme (ACE) inhibitors (ACE-Is) could act as a potential risk factor for fatal Corona virus disease 2019 (COVID-19) by up-regulating ACE2. This notion was quickly picked up by the lay press and sparked concerns among physicians and patients regarding the intake of inhibitors of the renin–angiotensin–aldosterone system (RAAS) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infected individuals.1 In this article, we try to shed light on what is known and unknown regarding the RAAS and SARS-CoV2 interaction.
    77浏览量
    原文链接

  • 《European Heart J，5月10日，Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-05-11
    • Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors Iziah E Sama, Alice Ravera, Bernadet T Santema, Harry van Goor, Jozine M ter Maaten, John G F Cleland, Michiel Rienstra, Alex W Friedrich, Nilesh J Samani, Leong L Ng ... Show more European Heart Journal, ehaa373, https://doi.org/10.1093/eurheartj/ehaa373 Abstract Aims The current pandemic coronavirus SARS-CoV-2 infects a wide age group but predominantly elderly individuals, especially men and those with cardiovascular disease. Recent reports suggest an association with use of renin–angiotensin–aldosterone system (RAAS) inhibitors. Angiotensin-converting enzyme 2 (ACE2) is a functional receptor for coronaviruses. Higher ACE2 concentrations might lead to increased vulnerability to SARS-CoV-2 in patients on RAAS inhibitors. Methods We measured ACE2 concentrations in 1485 men and 537 women with heart failure (index cohort). Results were validated in 1123 men and 575 women (validation cohort).
    18浏览量
    原文链接